ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.12	0.69	4.46	3.86	22.77	2.96
Cash & Short-Term Investments	4.12	0.69	4.46	3.86	22.77	2.96
Cash Growth	291.55%	-84.46%	15.67%	-83.07%	669.87%	0.75%
Accounts Receivable	0.78	0.99	1.66	2.18	2.82	2.62
Receivables	1.38	0.99	1.66	2.18	2.82	2.62
Inventory	2.55	2.46	3.74	3.61	3	2.24
Prepaid Expenses	0.71	0.33	0.2	0.08	1.12	0.91
Restricted Cash	0.1	0.1	0.1	0.1	0.05	0.05
Other Current Assets	-	0.01	0.14	0.08	0.19	0.16
Total Current Assets	8.86	4.59	10.3	9.91	29.94	8.94
Property, Plant & Equipment	0.11	0.15	0.31	0.87	1.72	1.05
Other Intangible Assets	-	-	-	0.26	20.83	27.02
Long-Term Deferred Tax Assets	0.03	0.02	0.03	0.06	-	-
Other Long-Term Assets	0.03	0.03	0.03	0.05	0.05	0.05
Total Assets	9.03	4.79	10.66	11.14	52.53	37.06
Accounts Payable	1.35	2.21	1.69	1.93	3.47	3.66
Accrued Expenses	1.59	0.89	0.86	2.15	2.13	2.45
Current Portion of Long-Term Debt	-	0.81	-	-	-	3.61
Current Portion of Leases	0.1	0.12	0.11	0.17	0.28	0.31
Current Income Taxes Payable	-	0.03	0.06	0.12	0.33	0.27
Other Current Liabilities	0.16	0.93	1.06	3.12	1.33	1.31
Total Current Liabilities	3.2	4.99	3.78	7.48	7.53	11.61
Long-Term Debt	-	-	-	-	-	9.17
Long-Term Leases	-	0.04	0.15	-	-	0.16
Long-Term Deferred Tax Liabilities	-	-	-	-	0.37	0.62
Other Long-Term Liabilities	-	0.02	0.07	-	0.3	1.02
Total Liabilities	3.2	5.05	4	7.48	8.2	22.57
Common Stock	-	-	-	0	-	0
Additional Paid-In Capital	649.8	642.56	642.33	627.94	622.4	529.43
Retained Earnings	-643.86	-642.7	-635.57	-624.19	-577.97	-514.83
Comprehensive Income & Other	-0.11	-0.1	-0.09	-0.09	-0.09	-0.12
Total Common Equity	5.83	-0.25	6.66	3.66	44.33	14.49
Shareholders' Equity	5.83	-0.25	6.66	3.66	44.33	14.49
Total Liabilities & Equity	9.03	4.79	10.66	11.14	52.53	37.06
Total Debt	0.1	0.97	0.26	0.17	0.28	13.25
Net Cash (Debt)	4.02	-0.27	4.2	3.68	22.49	-10.3
Net Cash Growth	380.17%	-	13.93%	-83.62%	-	-
Net Cash Per Share	49.41	-13.29	-	-	-	-
Filing Date Shares Outstanding	0.67	0.45	0.02	-	-	-
Total Common Shares Outstanding	0.66	0.03	0.02	-	-	-
Working Capital	5.66	-0.4	6.52	2.43	22.41	-2.66
Book Value Per Share	8.89	-8.66	411.88	-	-	-
Tangible Book Value	5.83	-0.25	6.66	3.4	23.51	-12.54
Tangible Book Value Per Share	8.89	-8.66	411.88	-	-	-
Machinery	-	0.15	0.15	0.94	1.36	0.34
Construction In Progress	-	-	-	0.07	0.41	0.4
Leasehold Improvements	-	-	-	0.02	0.02	0.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q